{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:07:15Z","timestamp":1792296435767,"version":"4.4.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Heat shock protein 90 alpha (Hsp90\u03b1) is one of the key intra- and extracellular chaperones responsible for the biological activity of various signaling molecules that are involved in (auto)immune-mediated inflammatory diseases. Recent epidemiologic data suggest that patients with atopic dermatitis (AD) are at risk for several autoimmune diseases, including dermatitis herpetiformis (DH), an extraintestinal manifestation of celiac disease (CD). In addition, pruritic diseases such as AD may be confused clinically with DH. In this study, we aimed to determine the role of circulating Hsp90\u03b1 in patients with AD in relation to patients with DH, CD, and healthy controls. Using an enzyme-linked immunosorbent assay, levels of circulating Hsp90\u03b1 were determined in serum samples derived from patients with AD (<jats:italic>n<\/jats:italic>\u2009=\u200931), DH (<jats:italic>n<\/jats:italic>\u2009=\u200926), CD (<jats:italic>n<\/jats:italic>\u2009=\u200915), and healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u200955). Although serum concentrations of Hsp90\u03b1 were similar between patients with DH, CD, and healthy controls, we found that serum levels of Hsp90\u03b1 were significantly higher (mean value of 5.08-fold; <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.0001) in patients with AD when compared to patients with DH. A cutoff value calculated as 2 \u00d7 standard deviation above the mean concentration of Hsp90\u03b1 in DH patients revealed that 83.9% (26\/31) of AD patients were Hsp90\u03b1 positive, whereas none of the DH patients (0\/26) displayed such a positivity. This preliminary study suggests a distinct role for extracellular Hsp90\u03b1 in the pathogenesis of AD compared to DH and its potential use in distinguishing AD from DH. Nevertheless, the potential role of the evaluation of extracellular Hsp90\u03b1 for distinguishing between AD and DH is at present speculative and requires further and careful observations.<\/jats:p>","DOI":"10.3389\/fmed.2023.1327144","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T05:08:13Z","timestamp":1704431293000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Differences in the detection of circulating Hsp90 alpha between patients with atopic dermatitis and dermatitis herpetiformis"],"prefix":"10.3389","volume":"10","author":[{"given":"Krzysztof","family":"Sitko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarolta","family":"K\u00e1rp\u00e1ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Mincewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Trzeciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kasperkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Tukaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/biom12081153","article-title":"Heat shock protein 90 (Hsp90) and Hsp70 as potential therapeutic targets in autoimmune skin diseases","volume":"12","author":"Tukaj","year":"2022","journal-title":"Biomol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/biom12070911","article-title":"Extracellular heat shock Protein-90 (eHsp90): everything you need to know","volume":"12","author":"Jay","year":"2022","journal-title":"Biomol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12192-014-0507-6","article-title":"Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis","volume":"19","author":"Kasperkiewicz","year":"2014","journal-title":"Cell Stress Chaperones"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s12192-021-01238-w","article-title":"Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis","volume":"26","author":"Sitko","year":"2021","journal-title":"Cell Stress Chaperones"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40257-020-00584-2","article-title":"Dermatitis herpetiformis: an update on diagnosis and management","volume":"22","author":"Reunala","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1028694","DOI":"10.3389\/fmed.2022.1028694","article-title":"Potential biomarkers of atopic dermatitis","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/medicina57080843","article-title":"Dermatitis herpetiformis: an update on diagnosis, disease monitoring, and management","volume":"57","author":"Nguyen","year":"2021","journal-title":"Medicina"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jid.2020.05.091","article-title":"Atopic dermatitis is associated with dermatitis herpetiformis and celiac disease in children","volume":"141","author":"Kauppi","year":"2021","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1651-2227.1986.tb10202.x","article-title":"HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis","volume":"75","author":"K\u00e1rp\u00e1ti","year":"1986","journal-title":"Acta Paediatr Scand"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/jdv.17183","article-title":"S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European academy of dermatology and venereology (EADV)","volume":"35","author":"G\u00f6r\u00f6g","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1610-0387.2009.07292.x","article-title":"Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring","volume":"8","author":"Rose","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jsbmb.2016.10.002","article-title":"Autoimmunity to heat shock proteins and vitamin D status in patients with celiac disease without associated dermatitis herpetiformis","volume":"173","author":"Tukaj","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/14737159.2023.2246883","article-title":"Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases","volume":"23","author":"Rivas-Macho","year":"2023","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1327144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T05:08:18Z","timestamp":1704431298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1327144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":14,"alternative-id":["10.3389\/fmed.2023.1327144"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1327144","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"article-number":"1327144"}}